Vu, Tuong N.
Chen, Xuesong
Foda, Hussein D.
Smaldone, Gerald C.
Hasaneen, Nadia A. http://orcid.org/0000-0001-6327-6029
Funding for this research was provided by:
Peter DeVito Memorial Foundation
Article History
Received: 10 September 2018
Accepted: 23 August 2019
First Online: 11 September 2019
Ethics approval and consent to participate
: Not applicable
: Not applicable
: The authors declare that they have no competing interests. New York University (NYU) and Stony Brook University (SBU) jointly hold patents on the treatment of lung disease with inhaled interferon gamma. These patents are licensed to InspiRx, Inc. Dr. Smaldone is a paid consultant to InspiRx, Inc.